Scope Biosciences has secured €6 million to advance its CRISPR-based diagnostics platform, aiming for more effective detection technology for agriculture and healthcare.
The concept that the near future could look very different - and the far future could be near unimaginable - has always fascinated and challenged me to consistently seek out new ways I could imagine the universe unfolding.